It had earlier acquired the healthcare business of L&T and later renamed Skanray Healthcare, and retained as a separate strategic business unit (SBU).
The new buy will give the company entry into the respiratory segment.
Also Read
"With this addition, we will be able to offer complete
ICU packages for hospitals and be a single point contact for Supply, Custom solutions and life cycle management of all its equipment in the ICU," he added.
Alva told Business Standard that it has adequate growth funds to serve investment purposes. Ascent Capital is said to be investing up to Rs 100 crore ($14.75 million) in Skanray Technologies in various tranches.
Skanray Technologies and Skanray Healthcare have about 12 USFDA-approved products are planning to have many of their new products compliant with European and US safety and performance standards,the company said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
